BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessAxim® Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain SufferersBy Nasdaq OMXNov 22, 2016, 2:00 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
